Article
Screening of Natural Compounds as P-Glycoprotein Inhibitors against Multidrug Resistance
30 Mar 2021
Abstract excerpt
Multidrug resistance (MDR) is a common problem when fighting cancer with chemotherapy. P-glycoprotein (P-gp, or MDR1) is an active pump responsible for the efflux of xenobiotics out of the cell, including anti-cancer drugs. It is a validated target against MDR. No crystal structure of the human P-gp is available to date, and only recently several cryo-EM structures have been solved. In this paper, we present a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
